Amifostine as a radioprotectant.
Gosselin
Tracy K
TK
Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA. gosse001@mc.duke.edu
Mautner
Beatrice
B
D004999:Amifostine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D004334:Drug Administration Schedule; D006258:Head and Neck Neoplasms / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D011832:Radiation Injuries / Q000517:prevention & control*; D011837:Radiation-Protective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*
D011837:Radiation-Protective Agents; D004999:Amifostine